Figure 1. Follow-up of patients with nephrotic syndrome and a level of CA-125 ≥ 35 U/mL at admission and during the period of study. The level was checked once a month, which was discontinued once a normal value of CA-125 (≤ 35 U/mL) was reached.
| World Journal of Nephrology and Urology, ISSN 1927-1239 print, 1927-1247 online, Open Access |
| Article copyright, the authors; Journal compilation copyright, World J Nephrol Urol and Elmer Press Inc |
| Journal website http://www.wjnu.org |
Short Communication
Volume 8, Number 1, March 2019, pages 14-16
Cancer Antigen 125 and Nephrotic Syndrome
Figure
Table
| Variable | At admission (n = 19) | CA 125 (U/mL) (median) | IQR (interquartile range) | P | Correlation coefficient |
|---|---|---|---|---|---|
| Age (years) | 45 | - | - | NS | |
| Gender | |||||
| Male | 13 | 578 | 54 - 1,382 | 0.726 | |
| Female | 6 | 202 | 39 - 1,385 | ||
| Urine output | |||||
| Normal | 7 | 45 | 34 - 203 | 0.004 | |
| Oliguria | 12 | 797 | 411 - 1,561 | ||
| Anuria | 0 | ||||
| Edema | 17 | 578 | 59 - 1,382 | 0.063 | |
| Ascites | 7 | 1,501 | 727 - 1,779 | 0.001 | |
| Laboratory | |||||
| Albumin (g/dL) | 1.9 | < 0.001 | -0.8 | ||
| Total Cholesterol (mg/dL) | 460 | 0.001 | 0.6 | ||
| Triglyceride (mg/dL) | 449 | 0.207 | 0.3 | ||
| Creatinine (mg/dL) | 2.36 | 0.012 | 0.5 | ||
| Urea (mg/dL) | 79 | 0.256 | 0.2 | ||
| Proteinuria (mg/24 h) | 12,412 | 0.314 | 0.2 | ||
| VSG (mm/h) | 100 | 0.34 | 0.3 |